Annals of Surgical Oncology

, Volume 25, Issue 3, pp 660–666 | Cite as

Core Body Temperature but Not Intraabdominal Pressure Predicts Postoperative Complications Following Closed-System Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Administration

  • M. Goldenshluger
  • D. Zippel
  • A. Ben-Yaacov
  • J. Dux
  • T. Yalon
  • A. Zendel
  • S. Rayman
  • E. Mor
  • H. Berkenstadt
  • H. Fogel-Grinvald
  • M. Ventorrero
  • A. Nissan
Gastrointestinal Oncology

Abstract

Background

Hyperthermic intraperitoneal chemotherapy (HIPEC) following cytoreductive surgery (CRS), performed using closed-abdomen technique (CAT), may affect intraabdominal pressure (IAP). High IAP may increase postoperative complications due to decreased venous return and hypoperfusion to vital organs. Elevated core body temperature (CBT) may cause multiorgan dysfunction. Low IAP or CBT could result in suboptimal HIPEC and potentially translate into early disease recurrence. The aim of the present study is to identify possible correlations between IAP or CBT and postoperative complications.

Patients and Methods

Continuous intraabdominal pressure measurement was performed by intraabdominal catheter. Inflow temperature was set at 44 °C, and mean perfusate temperature was 42 °C. CBT was measured continuously in the distal esophagus. We compared the rate of postoperative complications between the low IAP group (2–10 mmHg, n = 28), target IAP group (10–20 mmHg, n = 71), and high IAP group (20–34 mmHg, n = 16) as well as with CBT as a continuous variable.

Results

115 patients were included in the study. There was no difference between IAP groups in terms of age, gender, primary diagnosis, operative peritoneal cancer index, CBT, or operative time. There was no correlation between IAP and postoperative complications or with prolonged hospital stay. On multivariate analysis, elevated mean CBT was a positive predictor of postoperative complications (p = 0.035).

Conclusions

IAP level during closed-abdomen technique HIPEC is not associated with postoperative complications. However, elevated CBT may increase postoperative complications.

Notes

Disclosures

The authors have no commercial disclosures relevant to this work.

References

  1. 1.
    Maciver AH, Al-Sukhni E, Esquivel J, Skitzki JJ, Kane JM, Francescutti VA. Current delivery of hyperthermic intraperitoneal chemotherapy with cytoreductive surgery (CS/HIPEC) and perioperative practices: an international survey of high-volume surgeons. Ann Surg Oncol. 2016;  https://doi.org/10.1245/s10434-016-5692-3.
  2. 2.
    Neuwirth MG, Alexander HR, Karakousis GC. Then and now: cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC), a historical perspective. J Gastrointest Oncol. 2016;7(1):18–28.  https://doi.org/10.3978/j.issn.2078-6891.2015.106.PubMedPubMedCentralGoogle Scholar
  3. 3.
    Kanakoudis AF, Petrou A, Michaloudis D, Chortaria GKA. Anaesthesia for intra-peritoneal perfusion of hyperthermic chemotherapy. Anaesthesia. 1996;51:1033–36.CrossRefPubMedGoogle Scholar
  4. 4.
    Ortega-Deballon P, Facy O, Jambet S, Magnin G, Cotte E, Beltramo JL, Chauffert, et al. Which method to deliver hyperthermic intraperitoneal chemotherapy with oxaliplatin? An experimental comparison of open and closed techniques. Ann Surg Oncol. 2010;17(7):1957–63.  https://doi.org/10.1245/s10434-010-0937-z.CrossRefPubMedGoogle Scholar
  5. 5.
    Elias D, Franc G, Boutitie F, Quenet F, Bereder JM, Baudouin M, Lorimier G. Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: retrospective analysis of 523 patients from a multicentric French study. 2016;28(1):63–68.  https://doi.org/10.1200/jco.2009.23.9285.
  6. 6.
    Elias D, Antoun S, Goharin A, Otmany AE, Puizillout JM, Lasser P. Research on the best chemohyperthermia technique of treatment of peritoneal carcinomatosis after complete resection. Int J Surg Investig. 2000;1(5):0–1.Google Scholar
  7. 7.
    Dahl O. Status of clinical hyperthermia. Acta Oncol. 1999; 38: 863–73.  https://doi.org/10.1080/028418699432554 CrossRefPubMedGoogle Scholar
  8. 8.
    Kajdi M, Beck-schimmer B, Held U, Kofmehl R, Lehmann K, Ganter MT. Anaesthesia in patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: retrospective analysis of a single centre three-year experience. World J Surg Oncol. 2014;12(1):1–9.  https://doi.org/10.1186/1477-7819-12-136.CrossRefGoogle Scholar
  9. 9.
    Bouchama A, Knochel JP. Heat stroke. N Engl J Med. 2002;346(25):1978–88.CrossRefPubMedGoogle Scholar
  10. 10.
    Malbrain MLNG, Cheatham ML, Kirkpatrick A, Sugrue M, Parr M, Waele JD, Balogh H, et al. Results from the International Conference of experts on intra-ABDOMINAL hypertension and abdominal compartment syndrome. I. definitions. Intensive Care Med. 2006;32(11):1722–32.  https://doi.org/10.1007/s00134-006-0349-5.CrossRefPubMedGoogle Scholar
  11. 11.
    Sugarbaker PH. Peritonectomy procedures. Ann Surg. 1995;221(1):29–42.CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Dindo D, Demartines N, Clavien P-A. Classification of surgical complications. Ann Surg. 2004;240(2):205–213.  https://doi.org/10.1097/01.sla.0000133083.54934.ae.CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Ceelen WP, Flessner MF, et al. Intraperitoneal therapy for peritoneal tumors: biophysics and clinical evidence. Nat Rev Clin Oncol. 2010;7(2):108–15.  https://doi.org/10.1038/nrclinonc.2009.217.CrossRefPubMedGoogle Scholar
  14. 14.
    Kusamura S et al. Drugs, carrier solutions and temperature in hyperthermic intraperitoneal chemotherapy. J Surg Oncol. 2008;15;98(4):247–52CrossRefPubMedGoogle Scholar
  15. 15.
    Schaaf L, Kuip H, Zopf W, Winter S, Munch M, Murdter T, Thon KP, et al. A temperature of 40 °C appears to be a critical threshold for potentiating cytotoxic chemotherapy in vitro and in peritoneal carcinomatosis patients undergoing HIPEC. Ann Surg Oncol. 2015:758–65.  https://doi.org/10.1245/s10434-015-4853
  16. 16.
    Sessler DI. Perioperative thermoregulation and heat balance. Lancet. 2017;387(10038):2655–64.  https://doi.org/10.1016/s0140-6736(15)00981-2.CrossRefGoogle Scholar
  17. 17.
    Pelz JOW, Doerfer J, Decker M, Dimmler A, Hohenberger W, Meyer T. Hyperthermic intraperitoneal chemoperfusion (HIPEC) decrease wound strength of colonic anastomosis in a rat model. Int J Colorectal Dis. 2007:22:941–47.  https://doi.org/10.1007/s00384-006-0246-y.CrossRefPubMedGoogle Scholar
  18. 18.
    Lepock JR. How do cells respond to their thermal environment? Int J Hyperthermia. 2005;20:8.  https://doi.org/10.1080/02656730500307298
  19. 19.
    Samel S, Singal A, Becker H, Post S, Problems with intraoperative hyperthermic peritoneal chemotherapy for advanced gastric cancer. Eur J Surg Oncol. 2000; 26: 222–26.  https://doi.org/10.1053/ejso.1999.0780.CrossRefPubMedGoogle Scholar
  20. 20.
    Westermann AM, Wiedemann GJ, Jager E, Jager D, Katschinski DM, Knuth A, Vörde sive Vörding PZ. A Systemic Hyperthermia Oncologic Working Group trial. Oncology. 2003;53792:312–21.  https://doi.org/10.1159/000070287.CrossRefGoogle Scholar
  21. 21.
    Esquis P, Consolo D, Magnin G, Pointaire P, Moretto P, Ynsa MD, Beltramo JL, et al. High intra-abdominal pressure enhances the penetration and antitumor effect of intraperitoneal cisplatin on experimental peritoneal carcinomatosis. Ann Surg. 2006;244(1):106–112.  https://doi.org/10.1097/01.sla.0000218089.61635.5f.CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Facy O, Samman S, Magnin G, Ghiringhelli F, Ladoire S, Chauffert B, Rat P, Ortega-Deballon P. High pressure enhances the effect of hyperthermia in intraperitoneal chemotherapy with oxaliplatin. Ann Surg. 2012;0(0):1.  https://doi.org/10.1097/sla.0b013e3182582b38.PubMedGoogle Scholar
  23. 23.
    Gesson-Paute A, Ferron G, Thomas F, de Lara EC, Chatelut E, Querleu D. Pharmacokinetics of oxaliplatin during open versus laparoscopically assisted heated intraoperative intraperitoneal chemotherapy (HIPEC): an experimental study. Ann Surg Oncol. 2008;15(1):339–44.  https://doi.org/10.1245/s10434-007-9571-9.CrossRefPubMedGoogle Scholar
  24. 24.
    Malbrain MLNG. Different techniques to measure intra-abdominal pressure (IAP): time for a critical re-appraisal. Appl Physiol Intensive Care Med 2 Physiol Rev Ed. 2012:13–27.  https://doi.org/10.1007/978-3-642-28233-1_2.
  25. 25.
    Chopra SS, Wolf S, Rohde V, Freimann FB. Pressure measurement techniques for abdominal hypertension: conclusions from an experimental model. Crit Care Res Pract. 2015;  https://doi.org/10.1155/2015/278139.PubMedPubMedCentralGoogle Scholar

Copyright information

© Society of Surgical Oncology 2017

Authors and Affiliations

  1. 1.Department of General and Oncological-Surgery (Surgery C), Chaim Sheba Medical Center - Affiliated to the Sackler Faculty of MedicineTel Aviv UniversityTel HashomerIsrael
  2. 2.Department of Anesthesiology, Affiliated to the Sackler Faculty of MedicineTel Aviv UniversityTel HashomerIsrael
  3. 3.The Faculty of Medicine, School of Occupational TherapyHebrew UniversityJerusalemIsrael

Personalised recommendations